Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2019
A Look At The Financing, M&A And Alliance Activity In July–September 2019
Executive Summary
Device financing increased substantially in Q3, thanks to debt raises led by Insulet. Acquisition dollar volume dropped, though, but Siemens' buy of Corindus for $1.1bn was a stand-out. Diagnostics/research tools financing dropped by 28% from Q2, while acquisition value greatly increased due to Exact Sciences' $2.8bn purchase of Genomic Health.
You may also be interested in...
CMR Surgical Bags $240M, Ready For Robotics Surgery Launch
UK robotics firm CMR Surgical has landed $240m from investors as it prepares to launch its robotic surgery system in Europe and India. The Series C raise is Europe’s largest private financing round in the medical technology sector to date.
Stryker Closes Gap With Competitors In Strategic Spinal Robotics Acquisition
Stryker is acquiring point-of-care imaging company Mobius Imaging and spine robotics company Cardan Robotics in a deal worth up to $500m.
Molecular Diagnostic Firms Curetis And OpGen Announce Merger
The combination of the molecular diagnostic companies is structured as an acquisition of Curetis by OpGen. The merged companies will be a based in the US.